| Literature DB >> 33115976 |
Jun Oh Lee1, Chee-Hoon Lee1, Ho Jin Kim1, Joon Bum Kim1, Sung-Ho Jung1, Suk Jung Joo1, Cheol Hyun Chung1, Jae Won Lee1.
Abstract
BACKGROUND: Attaining an adequate effective orifice area (EOA) is definitive goal in aortic valve replacement (AVR). The simple interrupted suture (SIS) technique could be a solution to achieve this goal, but limited data are available in the literature. This study aimed to compare hemodynamic differences between the SIS and non-everting mattress suture (NMS) techniques.Entities:
Keywords: Aortic valve surgery; Effective orifice area; Heart valve prosthesis; Patient prosthetic mismatch; Surgery techniques
Year: 2020 PMID: 33115976 PMCID: PMC7721519 DOI: 10.5090/kjtcs.20.066
Source DB: PubMed Journal: Korean J Thorac Cardiovasc Surg ISSN: 2233-601X
Baseline characteristics and hemodynamic profiles in the SIS group and NMS group (N=215)
| Characteristic | SIS group (n=79) | NMS group (n=136) | p-value |
|---|---|---|---|
| Baseline characteristics | |||
| Age (yr) | 65.1±9.7 | 68.0±7.9 | 0.016 |
| Male sex | 46 (58.2) | 88 (64.7) | 0.382 |
| Body surface area (m2) | 1.7±0.2 | 1.7±0.1 | 0.056 |
| Body mass index (kg/m2) | 24.6±4.0 | 24.8±3.2 | 0.698 |
| Hypertension | 45 (57.0) | 73 (53.7) | 0.672 |
| Diabetes mellitus | 16 (20.3) | 28 (20.6) | >0.99 |
| Hyperlipidemia | 28 (35.4) | 52 (38.2) | 0.770 |
| Chronic kidney disease | 5 (6.3) | 6 (4.4) | 0.537 |
| Dialysis | 4 (5.1) | 5 (3.7) | 0.728 |
| Chronic obstructive pulmonary disease | 4 (5.1) | 14 (10.3) | 0.211 |
| Atrial fibrillation | 5 (6.3) | 13 (9.6) | 0.457 |
| Peripheral artery occlusive disease | 18 (22.8) | 32 (23.5) | >0.99 |
| Cerebrovascular accident | 8 (10.1) | 11 (8.1) | 0.625 |
| Hemoglobin | 12.9±1.9 | 12.9±1.6 | 0.736 |
| Echocardiography measurements | |||
| LVEF (%) | 60.5±9.7 | 57.6±12.8 | 0.085 |
| LVEF <40% | 5 (6.3) | 21 (15.4) | 0.053 |
| Aortic valve area (cm2) | 0.63±0.17 | 0.64±0.15 | 0.686 |
| Peak PG (mm Hg) | 105.2±28.4 | 101.3±32.0 | 0.370 |
| Mean PG (mm Hg) | 63.9±18.1 | 61.4±20.4 | 0.361 |
| Bicuspid aortic valve | 45 (57.0) | 64 (47.1) | 0.203 |
| Left ventricular outflow tract diameter (mm) | 20.9±1.6 | 21.1±1.7 | 0.373 |
| Computed tomography measurement | |||
| AV annulus diameter[ | 24.7±3.0 | 25.1±3.1 | 0.255 |
Values are presented as mean±standard deviation or number (%), unless otherwise indicated.
SIS, simple interrupted suture; NMS, non-everting mattress suture; LVEF, left ventricular ejection fraction; PG, pressure gradient; AV, aortic valve.
a)The AV annulus diameter was the mean value of the long and short axes.
Surgical profiles of the SIS group and NMS group (N=215)
| Variable | SIS group (n=79) | NMS group (n=136) | p-value |
|---|---|---|---|
| Prosthesis type | |||
| Mechanical valve | 33 (41.8) | 41 (30.1) | 0.102 |
| ATS AP | 6 (18.2) | 24 (58.5) | |
| Bicarbon | 3 (9.1) | - | |
| On-X | 4 (12.1) | 2 (4.9) | |
| Overline | 3 (9.1) | - | |
| SJM Regent | 17 (51.5) | 15 (36.6) | |
| Bioprosthesis | 46 (58.2) | 95 (69.9) | 0.102 |
| Perimount Magna | 26 (56.5) | 39 (41.1) | |
| Hancock bioprosthesis | 4 (8.7) | 38 (40.0) | |
| Mitroflow | 2 (4.3) | 9 (9.5) | |
| Mosaic bioprosthesis | - | 2 (2.1) | |
| Trifecta | 14 (30.4) | 7 (7.4) | |
| Valve size (mm) | |||
| 18–20 (prosthesis) | 7 (8.9) | 21 (15.4) | |
| 21–22 (prosthesis) | 20 (25.3) | 51 (37.5) | |
| 23–24 (prosthesis) | 29 (36.7) | 39 (28.7) | |
| 25–27 (prosthesis) | 23 (29.1) | 25 (18.4) | |
| Prosthesis-annulus size ratio | 0.94±0.09 | 0.89±0.07 | <0.001 |
| Minimally invasive approach | 46 (58.2) | 24 (17.6) | <0.001 |
| Isolated aortic valve repair | 58 (73.4) | 83 (61.0) | 0.075 |
| Concomitant procedure | 21 (26.6) | 53 (39.0) | 0.075 |
| Aortic surgery | 8 (10.2) | 21 (15.4) | |
| Bypass surgery | 5 (6.3) | 23 (16.9) | |
| Valve repair surgery | 5 (6.4) | 6 (4.4) | |
| Arrhythmia surgery | 6 (7.7) | 7 (5.3) | |
| Atrial septal defect repair | 2 (2.5) | 2 (1.5) | |
| Cardiopulmonary bypass time (min) | 118.6±38.2 | 113.5±41.0 | 0.36 |
| Aortic cross clamp time (min) | 76.9±27.4 | 78.1±28.2 | 0.77 |
Values are presented as number (%) or mean±standard deviation, unless otherwise indicated. Valve names are sorted in ascending alphabetical order: ATS AP (Medtronic Inc., Minneapolis, MN, USA), Bicarbon (Sorin Group USA Inc., Arvada, CO, USA), Hancock bioprosthesis (Medtronic Inc., Minneapolis, MN, USA), Mitroflow (Sorin Group USA Inc., Arvada, CO, USA), Mosaic bioprosthesis (Medtronic Inc., Minneapolis, MN, USA), On-X (On-X Life Technologies Inc., Austin, TX, USA), Overline (Sorin Group USA Inc., Arvada, CO, USA), Perimount Magna (Edwards Lifesciences, Irvine, CA, USA), SJM Regent (St. Jude Medical Inc., St. Paul, MN, USA), and Trifecta (St. Jude Medical Inc., St. Paul, MN, USA).
SIS, simple interrupted suture; NMS, non-everting mattress suture.
Postoperative valve performance data from echocardiography (N=215)
| Variable | SIS group (n=79) | NMS group (n=136) | p-value |
|---|---|---|---|
| First postoperative echocardiography (within 5 days) | |||
| LVEF (%) | 60.3±8.4 | 58.3±10.9 | 0.184 |
| EOA (cm2) | 1.6±0.4 | 1.4±0.5 | 0.007 |
| EOA index (cm2/m2) | 1.0±0.2 | 0.9±0.3 | 0.021 |
| Peak PG (mm Hg) | 24.6±9.9 | 31.1±11.1 | <0.001 |
| Mean PG (mm Hg) | 13.3±5.4 | 17.0±6.0 | <0.001 |
| LVOT diameter (mm) | 20.4±1.5 | 20.1±1.7 | 0.285 |
| PVL | 1 (1.3) | 7 (5.1) | 0.451 |
| Trivial | 0 | 3 | |
| Mild | 1 | 3 | |
| Mild to moderate | 0 | 1 | |
| Second follow-up echocardiography[ | |||
| LVEF (%) | 63.2±5.6 | 61.8±7.1 | 0.150 |
| EOA (cm2) | 1.6±0.4 | 1.4±0.3 | <0.001 |
| EOA index (cm2/m2) | 0.9±0.2 | 0.8±0.2 | 0.001 |
| Peak PG (mm Hg) | 20.5±8.4 | 26.1±9.6 | <0.001 |
| Mean PG (mm Hg) | 10.9±5.1 | 14.1±5.4 | <0.001 |
| LVOT diameter (mm) | 20.1±1.4 | 20.0±1.5 | 0.766 |
| PVL | 3 (4.2) | 9 (6.6) | 0.39 |
| Trivial | 1 | 3 | |
| Mild | 2 | 4 | |
| Mild to moderate | 0 | 2 | |
| Third follow-up echocardiography[ | |||
| PVL | 5 (6.4) | 14 (10.3) | 0.3 |
| Trivial | 2 | 2 | |
| Mild | 2 | 9 | |
| Mild to moderate | 1 | 3 |
Values are presented as mean±standard deviation or number (%), unless otherwise indicated.
SIS, simple interrupted suture; NMS, non-everting mattress suture; LVEF, left ventricular ejection fraction; EOA, effective orifice area; PG, pressure gradient; LVOT, left ventricular outflow tract; PVL, paravalvular leakage.
a)Median follow-up duration (1–3 quartile): 9.6 months (interquartile range, 5.8–12.9 months). b)Median follow-up duration (1–3 quartile): 26 months (interquartile range, 8–46 months).
Subgroup analysis of postoperative valve performance on the second follow-up[a)] echocardiography according to prosthetic valve size (N=215)
| Variable | SIS group | NMS group | p-value |
|---|---|---|---|
| Valve size 18–23 mm | |||
| No. of patients | 52 | 108 | |
| EOA (cm2) | 1.49±0.4 | 1.32±0.3 | <0.01 |
| EOA index (cm2/m2) | 0.92±0.2 | 0.81±0.2 | <0.01 |
| Peak PG (mm Hg) | 21.9±8.7 | 27.4±10.0 | <0.01 |
| Mean PG (mm Hg) | 16.8±6.4 | 21.12±7.5 | <0.01 |
| Valve size >23 mm | |||
| No. of patients | 27 | 28 | |
| EOA (cm2) | 1.74±0.4 | 1.6±0.3 | 0.06 |
| EOA index (cm2/m2) | 1.0±0.3 | 0.9±0.2 | 0.15 |
| Peak PG (mm Hg) | 17.3±7.0 | 22.4±7.0 | 0.02 |
| Mean PG (mm Hg) | 13.2±5.1 | 17.15±5.2 | 0.03 |
Values are presented as mean±standard deviation or number, unless otherwise indicated.
SIS, simple interrupted suture; NMS, non-everting mattress suture; EOA, effective orifice area; PG, pressure gradient.
a)Median follow-up duration (1–3 quartile): 9.6 months (interquartile range, 5.8–12.9 months).